JK

John King-Underwood

RE Respivert: 7 patents #2 of 32Top 7%
TL Topivert Pharma Limited: 2 patents #4 of 21Top 20%
📍 Ledbury, GB: #1 of 2 inventorsTop 50%
Overall (2017): #15,330 of 506,227Top 4%
7
Patents 2017

Issued Patents 2017

Showing 1–7 of 7 patents

Patent #TitleCo-InventorsDate
9850231 1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-I-yl) ureas as P38 mapkinase inhibitors Kazuhiro Ito, Catherine Elisabeth Charron, Stuart Thomas Onions, Alistair Ian Longshaw, Rudy Laurent Maria Broeckx +2 more 2017-12-26
9834560 Compounds Kazuhiro Ito, Peter John Murray, George Hardy, Frederick Arthur Brookfield, Christopher John Brown 2017-12-05
9771354 Pyrazole p38 map kinase inhibitors George Hardy, Peter John Murray, Jonathan Gareth Williams, Stuart Thomas Onions 2017-09-26
9724347 1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl)oxy)napththalen-1-yl) ureas as P38 MAP knase inhibitors Kazuhiro Ito, Catherine Elisabeth Charron, Stuart Thomas Onions, Alistair Ian Longshaw 2017-08-08
9701670 Pyrazolyl-ureas as kinase inhibitors Claire Anne Marie Cariou, Catherine Elisabeth Charron, Euan Alexander Fraser Fordyce, Daniel Hamza, Matthew Colin Thor Fyfe +6 more 2017-07-11
9637494 Quinazolin-4 (3H)-one derivatives used as P13 kinase inhibitors Kazuhiro Ito, Peter John Murray, George Hardy, Frederick Arthur Brookfield, Christopher John Brown 2017-05-02
9624196 Inhibitor of p38 MAP kinase Alistair Ian Longshaw, Euan Alexander Fraser Fordyce, Stuart Thomas Onions, Jennifer D. Venable 2017-04-18